stock.name

Incyte Corp.

INCY

Market Cap$12.77B
Close$

Compare Incyte

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Incyte Corp.Incyte Corp.17.10%14%3.6-
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$61.00

Target Price by Analysts

6.8% upsideIncyte Target Price DetailsTarget Price
$123.39

Current Fair Value

116.1% upside

Undervalued by 116.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.77 Billion
Enterprise Value$8.95 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$3.29
Beta0.33
Outstanding Shares224,540,751
Avg 30 Day Volume2,547,094

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio17.13
PEG2.51
Price to Sales3.57
Price to Book Ratio2.38
Enterprise Value to Revenue2.38
Enterprise Value to EBIT12.56
Enterprise Value to Net Income12
Total Debt to Enterprise0
Debt to Equity0.01

Revenue Sources

No data

ESG Score

No data

About Incyte Corp.

CEO: Paul Friedman